Drug survival rate of dupilumab in Japanese patients with atopic dermatitis
Guardado en:
Autores principales: | Susumu Ichiyama, Michiko Ito, Toshihiko Hoashi, Naoko Kanda, Hidehisa Saeki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd67de0ed1314b13b2e1e62003fb6184 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis
por: Jonathan I. Silverberg, et al.
Publicado: (2021) -
Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
por: Hanna Niehues, et al.
Publicado: (2022) -
Update: Can breastfeeding and maternal diet prevent atopic dermatitis?
por: Colleen Little, et al.
Publicado: (2017) -
Development of diffuse large B‐cell lymphoma during dupilumab treatment in a patient with atopic dermatitis: A case report
por: Hideaki Uchida, et al.
Publicado: (2021) -
Emerging Roles of Adipose Tissue in the Pathogenesis of Psoriasis and Atopic Dermatitis in Obesity
por: Zhuolin Guo, et al.
Publicado: (2022)